Navigation Links
University of Michigan Wolverine Venture Fund Invests in Delphinus Medical Technologies
Date:6/3/2010

Student-Led Venture Fund Participates in $8 Million Series A Round of Financing led by Co-Investor Arboretum Ventures

ANN ARBOR, Mich., June 3 /PRNewswire/ -- The Wolverine Venture Fund (WVF), managed by The Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies at the University of Michigan Ross School of Business, today announced participation in an $8 million series A round of financing for Delphinus Medical Technologies, Inc.  

Detroit-based Delphinus Medical Technologies, Inc., a spin-out from the Karmanos Cancer Institute, has developed an automated whole-breast ultrasound imaging system for breast cancer detection, risk evaluation, and treatment monitoring.  Delphinus will use the funding to complete the commercial product design and file for regulatory clearance.

With more than ten years of investment and innovation, the $5.2 million Wolverine Venture Fund is the country's first student-led venture fund and has served as a model for other university programs over the years.  Since its inception, the Wolverine Venture Fund has invested in more than 18 companies in a wide range of innovative industries such as information technology, life sciences and alternative energy.

The WVF student team responsible for conducting due diligence and spearheading the investment represented a mix of business, accounting and healthcare consulting expertise, all of which contributed to the review and co-investment process.  The student team included Carrie Frost, Ross BBA 2009 and University of Michigan Master of Accounting 2010; Erica Kang, Ross MBA 2011; Kanishka Thakur, Ross MBA 2011; and Michael Johnson, Ross MBA 2011 and University of Michigan Medical School MD 2011.

"Our investment in Delphinus marks another exciting investment for the Wolverine Venture Fund in the medical device market,"  said Tom Kinnear, Executive Director of the Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies and Wolverine Venture Fund Director.  "This new financing will provide the critical funds that Delphinus needs to commercialize its product and manage the regulatory filing process, while providing our students real-world investing experience in a large and fast-growing market sector.  We're confident that our student-run team's deep experience in the medical device and imaging markets will pay significant dividends for Delphinus beyond the infusion of capital."

About the Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies / Center for Venture Capital & Private Equity Finance at the Ross School of Business at the University of Michigan

The Institute and its Center for Venture Capital and Private Equity Finance bring together a potent mix of knowledge, experience and opportunities from the front lines of entrepreneurship and alternative investments. The student learning experience is further enhanced through internships, entrepreneurial clubs and organization and events that serve to provide viable networks and engage the business community. The School's two student-led investment funds, with over $5M in management, immerse students in the business assessment and investment process. Members of the Advisory Board include Samuel Zell, Chairman of Equity Group Investments; Michael Hallman, former COO of Microsoft Corporation; and Eugene Applebaum, Founder of Arbor Drugs, Inc.  For more information, visit the Institute at www.zli.bus.umich.edu.


'/>"/>
SOURCE Samuel Zell & Robert H. Lurie Institute for Entrepreneurial Studies
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. John DeVincenzo, MD, at the University of Tennessee Health Science Center Discovers First Evidence that RNA-interference Drugs Reduce Human Disease
2. University HealthSystem Consortium Selects Centurion Service Group for Equipment and Asset Liquidation Services
3. Binder Biomedical, Inc. Announces the Release of the X-GRAFT(TM) Interspinous Device, as Part of Their QUANTUM(TM) Line of Spinal Allograft Devices, Manufactured at the University of Miami Tissue Bank
4. Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy
5. 2nd Annual Orthopedic Design & Technology Forum Returns April 28 to the FedEx Institute of Technology, University of Memphis
6. TechniScan Launches 3-D Breast Ultrasound Clinical Study in Freiburg University
7. IVF FLORIDA Reproductive Associates Partners with The University of Miami School of Medicine and Jackson Memorial Health
8. Caliper Life Sciences and Stanford University File a Patent Infringement Lawsuit Against Carestream Health, Inc.
9. Innovative University of Cincinnati Program Trains Next Generation of Pharmaceutical Professionals
10. Medical University of South Carolina First To Test New Heart Imaging Method To Detect Coronary Artery Disease
11. Draeger Donating Mechanical Ventilators and Anesthesia Machines to University of Miami - Aid for Haiti Earthquake Disaster
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... DUBLIN , Feb 24, 2017 Research ... Drugs Price Analysis and Strategies - 2016" report to their ... The ... provides drug pricing data and benchmarks in the global Urinary Incontinence ... What are the key drugs marketed for Urinary Incontinence ...
(Date:2/23/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device company ... the urology market, will release financial results for the ... before the market open on Thursday, March 9, 2017. ... call and webcast to discuss its financial results the ... a.m. Eastern Time (10:00 a.m. Central Time). Darin ...
(Date:2/23/2017)... 23, 2017 Research and Markets has announced ... Strategies - 2016" report to their offering. ... The latest research Oesophageal Cancer ... and benchmarks in the global Oesophageal Cancer market. The ... are the key drugs marketed for Oesophageal Cancer and their clinical ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Rosica ... in thought leadership , media relations, social media, content marketing and SEO, ... be powered through Act-On, an intuitive marketing automation platform. , Rosica will now ...
(Date:2/23/2017)... ... 23, 2017 , ... On February 22, 2017 the U.S. ... to withdraw previous guidance issued by the Obama Administration requiring schools to treat ... 2016 by the Obama Administration came in response to a growing number of ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The American Cleft ... ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the event. , ... exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has ...
(Date:2/23/2017)... ... February 23, 2017 , ... EBSCO Information Services ... Institute for Health and Care Excellence (NICE) framework. The agreement allows purchasers ... (NHS) to search, order and purchase medical and healthcare-related content through GOBI ...
(Date:2/23/2017)... ... , ... ERT, a global data and technology company that ... leading clinical development service provider, has selected ERT’s Trial Oversight suite as its ... to an array of circumstances including the use of multiple data capture modalities ...
Breaking Medicine News(10 mins):